NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
13/10/2025
Voltar para busca
Dado oficial do USPTO
ALZHEIMER'S DISEASE RESEARCH
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ALZHEIMER'S DISEASE RESEARCH
ST13
US500000086168764Classe
9, 16, 35, 36, 41, 42, 44
Pedido
86168764
Registro
4779133
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
45
Atualização mais recente
04/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 16, 35, 36, 41, 42, 44
Data de depósito
17/01/2014
Data de registro
21/07/2015
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/10/2025
Última transação
04/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Supplemental Register
Fundamento do pedido
Intent to use
Primeiro uso
16/04/2015
Primeiro uso no comércio
16/04/2015
Código do desenho
4
Tipo de titular
03
Localização do titular
Clarksburg, MD
Examinador
CROWLEY, PAUL
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
B. F. (pessoa física)
Representantes
Joseph W. Berenato, III Calderon Safran & Wright PC
Classificação técnica
Classes Nice
Classe 9Classe 16Classe 35Classe 36Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable research report updates in the field of diseases of sight and mind; Downloadable audio files in the nature of audio clips in the field of age-related and degenerative diseases
Classe 16
Printed educational materials featuring information in the field of age-related and degenerative diseases; printed research report updates in the field of diseases of sight and mind
Classe 35
Public advocacy to promote awareness of the importance of and critical issues regarding age-related and degenerative diseases; promoting public awareness in the field of age-related and degenerative diseases through dissemination of public educational information about disease risk factorspreventative lifestylescurrent treatments and coping strategies; Providing an online directory of service provider organizations that provide caregiver supportfinancial and legal assistancesenior housing and information on government programs; Providing referrals of service providers in the field of age-related and degenerative diseases
Classe 36
Providing research grants in the field of age-related and degenerative diseases; Clinical trial funding; charitable fundraising
Classe 41
Providing ongoing public service announcements via radiotelevision and the internet in the field of age-related and degenerative diseases; Providing on-line electronic newsletters delivered by e-mail in the field of age-related and degenerative diseases; Providing a website featuring non-downloadable videos and podcasts in the field of age related and degenerative diseases; Providing a website featuring lists of books and publications that provide information and coping strategies in the field of age-related and degenerative diseases
Classe 42
Providing a website featuring technology that enables users to share stories and caregiving tips in the field of age-related and degenerative diseases
Classe 44
Providing medical information via an online web site in the field of age-related and degenerative diseases; Providing medical information in the field of age-related and degenerative diseases via the social media websites of others; Providing a website featuring medical informationnon-downloadable medical illustrations
Publicações
Histórico de despachos e eventos da marca no USPTO.
45 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
13/10/2025
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
13/10/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/10/2025
E89R
TEAS SECTION 8 & 9 RECEIVED
20/06/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
21/07/2024
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
25/01/2023
PC.D
PETITION TO DIRECTOR DISMISSED
25/01/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/01/2023
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
25/01/2023
REIN
REINSTATED
25/01/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
24/01/2023
APET
ASSIGNED TO PETITION STAFF
20/01/2023
TPDR
TEAS PETITION TO DIRECTOR RECEIVED
18/05/2022
NCS8
NOTICE OF CANCELLATION SEC. 8 EMAILED
17/05/2022
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
16/05/2022
C8..
CANCELLED SEC. 8 (6-YR)
16/05/2022
PRA8
POST REGISTRATION ACTION MAILED - SEC. 8
15/11/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
15/11/2021
ES8R
TEAS SECTION 8 RECEIVED
30/06/2021
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
21/07/2020
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
21/07/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/06/2015
ALIE
ASSIGNED TO LIE
12/06/2015
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
26/05/2015
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
25/05/2015
IUAA
USE AMENDMENT ACCEPTED
25/05/2015
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
20/05/2015
IUAF
USE AMENDMENT FILED
20/05/2015
EAAU
TEAS AMENDMENT OF USE RECEIVED
19/05/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
19/05/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
19/05/2015
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
19/05/2015
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
21/11/2014
GNFR
FINAL REFUSAL E-MAILED
21/11/2014
CNFR
FINAL REFUSAL WRITTEN
21/11/2014
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
30/10/2014
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
30/10/2014
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/10/2014
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
30/10/2014
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/04/2014
GNRT
NON-FINAL ACTION E-MAILED
30/04/2014
CNRT
NON-FINAL ACTION WRITTEN
30/04/2014
DOCK
ASSIGNED TO EXAMINER
22/04/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
30/01/2014
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALZHEIMER'S DISEASE RESEARCH ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.